Literature DB >> 23476056

Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α.

Shouji Matsushima1, Junya Kuroda, Tetsuro Ago, Peiyong Zhai, Yoshiyuki Ikeda, Shinichi Oka, Guo-Hua Fong, Rong Tian, Junichi Sadoshima.   

Abstract

RATIONALE: NADPH oxidase (Nox) 2 and Nox4 are major components of the Nox family which purposefully produce reactive oxidative species, namely O2(-) and H2O2, in the heart. The isoform-specific contribution of Nox2 and Nox4 to ischemia/reperfusion (I/R) injury is poorly understood.
OBJECTIVE: We investigated the role of Nox2 and Nox4 in mediating oxidative stress and myocardial injury during I/R using loss-of-function mouse models. METHODS AND
RESULTS: Systemic (s) Nox2 knockout (KO), sNox4 KO, and cardiac-specific (c) Nox4 KO mice were subjected to I/R (30 minutes/24 hours, respectively). Both myocardial infarct size/area at risk and O2(-) production were lower in sNox2 KO, sNox4 KO, and cNox4 KO than in wild-type mice. Unexpectedly, however, the myocardial infarct size/area at risk was greater, despite less O2(-) production, in sNox2 KO+cNox4 KO (double-KO) mice and transgenic mice (Tg) with cardiac-specific expression of dominant-negative Nox, which suppresses both Nox2 and Nox4, than in wild-type or single KO mice. Hypoxia-inducible factor-1α was downregulated whereas peroxisome proliferator-activated receptor-α was upregulated in Tg-dominant-negative Nox mice. A cross with mice deficient in prolyl hydroxylase 2, which hydroxylates hypoxia-inducible factor-1α, rescued the I/R injury and prevented upregulation of peroxisome proliferator-activated receptor-α in Tg-dominant-negative Nox mice. A cross with peroxisome proliferator-activated receptor-α KO mice also attenuated the injury in Tg- dominant-negative Nox mice.
CONCLUSIONS: Both Nox2 and Nox4 contribute to the increase in reactive oxidative species and injury by I/R. However, low levels of reactive oxidative species produced by either Nox2 or Nox4 regulate hypoxia-inducible factor-1α and peroxisome proliferator-activated receptor-α, thereby protecting the heart against I/R, suggesting that Noxs also act as a physiological sensor for myocardial adaptation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23476056      PMCID: PMC3871171          DOI: 10.1161/CIRCRESAHA.111.300171

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

Review 1.  Oxidants, oxidative stress and the biology of ageing.

Authors:  T Finkel; N J Holbrook
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

2.  High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation.

Authors:  Que Liu; John C Docherty; John C T Rendell; Alexander S Clanachan; Gary D Lopaschuk
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis.

Authors:  R Tian; E D Abel
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

4.  Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice.

Authors:  M R Hoffmeyer; S P Jones; C R Ross; B Sharp; M B Grisham; F S Laroux; T J Stalker; R Scalia; D J Lefer
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

5.  Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia.

Authors:  S Narravula; S P Colgan
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.

Authors:  Tian-li Yue; Weike Bao; Beat M Jucker; Juan-li Gu; Anne M Romanic; Peter J Brown; Jianqi Cui; Douglas T Thudium; Rogely Boyce; Cynthia L Burns-Kurtis; Rosanna C Mirabile; Karpagam Aravindhan; Eliot H Ohlstein
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

7.  Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

Authors:  Martin E Young; Patrick H Guthrie; Peter Razeghi; Brendan Leighton; Shahrzad Abbasi; Sarita Patil; Keith A Youker; Heinrich Taegtmeyer
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

8.  Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species.

Authors:  Parag Goyal; Norbert Weissmann; Friedrich Grimminger; Cornelia Hegel; Lucius Bader; Frank Rose; Ludger Fink; Hossein A Ghofrani; Ralph T Schermuly; Harald H H W Schmidt; Werner Seeger; Jörg Hänze
Journal:  Free Radic Biol Med       Date:  2004-05-15       Impact factor: 7.376

9.  Determination and comparison of specific activity of the HIF-prolyl hydroxylases.

Authors:  Jason R Tuckerman; Yuguang Zhao; Kirsty S Hewitson; Ya-Min Tian; Christopher W Pugh; Peter J Ratcliffe; David R Mole
Journal:  FEBS Lett       Date:  2004-10-08       Impact factor: 4.124

10.  JunD reduces tumor angiogenesis by protecting cells from oxidative stress.

Authors:  Damien Gerald; Edurne Berra; Yves M Frapart; Denise A Chan; Amato J Giaccia; Daniel Mansuy; Jacques Pouysségur; Moshe Yaniv; Fatima Mechta-Grigoriou
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

View more
  60 in total

Review 1.  Pyridine Dinucleotides from Molecules to Man.

Authors:  Joshua P Fessel; William M Oldham
Journal:  Antioxid Redox Signal       Date:  2017-07-25       Impact factor: 8.401

Review 2.  Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.

Authors:  Reza Badalzadeh; Behnaz Mokhtari; Raana Yavari
Journal:  J Physiol Sci       Date:  2015-03-01       Impact factor: 2.781

Review 3.  Therapeutic potential of NADPH oxidase 1/4 inhibitors.

Authors:  G Teixeira; C Szyndralewiez; S Molango; S Carnesecchi; F Heitz; P Wiesel; J M Wood
Journal:  Br J Pharmacol       Date:  2016-07-14       Impact factor: 8.739

4.  Hypoxia-induced suppression of c-Myc by HIF-2α in human pulmonary endothelial cells attenuates TFAM expression.

Authors:  Ali J Zarrabi; Derrick Kao; Dustin T Nguyen; Joseph Loscalzo; Diane E Handy
Journal:  Cell Signal       Date:  2017-07-12       Impact factor: 4.315

Review 5.  Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications.

Authors:  Thomas Münzel; Tommaso Gori; John F Keaney; Christoph Maack; Andreas Daiber
Journal:  Eur Heart J       Date:  2015-07-04       Impact factor: 29.983

6.  Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice.

Authors:  B Wu; K Meng; Q Ji; M Cheng; K Yu; X Zhao; H Tony; Y Liu; Y Zhou; C Chang; Y Zhong; Z Zhu; W Zhang; X Mao; Q Zeng
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 7.  ROS signaling and ER stress in cardiovascular disease.

Authors:  Cristhiaan D Ochoa; Ru Feng Wu; Lance S Terada
Journal:  Mol Aspects Med       Date:  2018-03-22

8.  Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling.

Authors:  Shouji Matsushima; Junya Kuroda; Peiyong Zhai; Tong Liu; Shohei Ikeda; Narayani Nagarajan; Shin-Ichi Oka; Takashi Yokota; Shintaro Kinugawa; Chiao-Po Hsu; Hong Li; Hiroyuki Tsutsui; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

Review 9.  Responses to reductive stress in the cardiovascular system.

Authors:  Diane E Handy; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2016-12-08       Impact factor: 7.376

10.  HAX-1 regulates SERCA2a oxidation and degradation.

Authors:  Philip A Bidwell; Guan-Sheng Liu; Narayani Nagarajan; Chi Keung Lam; Kobra Haghighi; George Gardner; Wen-Feng Cai; Wen Zhao; Luke Mugge; Elizabeth Vafiadaki; Despina Sanoudou; Jack Rubinstein; Djamel Lebeche; Roger Hajjar; Junichi Sadoshima; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2017-11-21       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.